NASDAQ
QSAM

Qsam Biosciences Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Qsam Biosciences Inc Stock Price

Vitals

Today's Low:
$4.6
Today's High:
$4.6
Open Price:
$4.6
52W Low:
$3.51
52W High:
$6.2
Prev. Close:
$4.8
Volume:
100

Company Statistics

Market Cap.:
$15.19 million
Book Value:
-0.509
Revenue TTM:
$-191199
Operating Margin TTM:
0%
Gross Profit TTM:
$916667
Profit Margin:
0%
Return on Assets TTM:
-591.34%
Return on Equity TTM:
-3377.07%

Company Profile

Qsam Biosciences Inc had its IPO on 2015-12-11 under the ticker symbol QSAM.

The company operates in the Healthcare sector and Biotechnology industry. Qsam Biosciences Inc has a staff strength of 4 employees.

Stock update

Shares of Qsam Biosciences Inc opened at $4.6 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.6 - $4.6, and closed at $4.6.

This is a -4.17% slip from the previous day's closing price.

A total volume of 100 shares were traded at the close of the day’s session.

In the last one week, shares of Qsam Biosciences Inc have slipped by -0.43%.

Qsam Biosciences Inc's Key Ratios

Qsam Biosciences Inc has a market cap of $15.19 million, indicating a price to book ratio of 110.9689 and a price to sales ratio of 1.7134.

In the last 12-months Qsam Biosciences Inc’s revenue was $-191199 with a gross profit of $916667 and an EBITDA of $-1299805. The EBITDA ratio measures Qsam Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Qsam Biosciences Inc’s operating margin was 0% while its return on assets stood at -591.34% with a return of equity of -3377.07%.

In Q2, Qsam Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 22.2%.

Qsam Biosciences Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-2.6 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Qsam Biosciences Inc’s profitability.

Qsam Biosciences Inc stock is trading at a EV to sales ratio of 18.2559 and a EV to EBITDA ratio of -1.3087. Its price to sales ratio in the trailing 12-months stood at 1.7134.

Qsam Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$462612.00
Total Liabilities
$1.38 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Qsam Biosciences Inc ended 2024 with $462612.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $462612.00 while shareholder equity stood at $-915278.00.

Qsam Biosciences Inc ended 2024 with $0 in deferred long-term liabilities, $1.38 million in other current liabilities, 324.00 in common stock, $-38469938.00 in retained earnings and $0 in goodwill. Its cash balance stood at $389690.00 and cash and short-term investments were $389690.00. The company’s total short-term debt was $7,500 while long-term debt stood at $0.

Qsam Biosciences Inc’s total current assets stands at $462612.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $911744.00 and inventory worth $0.

In 2024, Qsam Biosciences Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Qsam Biosciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$4.6
52-Week High
$6.2
52-Week Low
$3.51
Analyst Target Price
$

Qsam Biosciences Inc stock is currently trading at $4.6 per share. It touched a 52-week high of $6.2 and a 52-week low of $6.2. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $4.56 and 200-day moving average was $4.67 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5221.8% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Qsam Biosciences Inc

The stock symbol (also called stock or share ticker) of Qsam Biosciences Inc is QSAM

The IPO of Qsam Biosciences Inc took place on 2015-12-11

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$27
-1.35
-4.76%
$1464.4
4.15
+0.28%
$293.3
-3.15
-1.06%
$12.78
-0.48
-3.62%
$81.65
-0.93
-1.13%
$3.97
0.03
+0.76%
$3087.75
-64.4
-2.04%
$13.03
0.28
+2.2%
$0.17
0
0%
$20.07
-0.1
-0.5%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. The company was incorporated in 2004 and is headquartered in Austin, Texas.

Address

Plaza 1, Austin, TX, United States, 78759